Show simple item record

dc.contributor.authorLee, Crystal
dc.contributor.authorHuxley, Rachel
dc.contributor.authorWoodward, M.
dc.contributor.authorZimmet, P.
dc.contributor.authorShaw, J.
dc.contributor.authorCho, N.
dc.contributor.authorKim, H.
dc.contributor.authorViali, S.
dc.contributor.authorTominaga, M.
dc.contributor.authorVistisen, D.
dc.contributor.authorBorch-Johnsen, K.
dc.contributor.authorColagiuri, S.
dc.date.accessioned2017-01-30T12:06:16Z
dc.date.available2017-01-30T12:06:16Z
dc.date.created2016-09-12T08:36:30Z
dc.date.issued2008
dc.identifier.citationLee, C. and Huxley, R. and Woodward, M. and Zimmet, P. and Shaw, J. and Cho, N. and Kim, H. et al. 2008. The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Research and Clinical Practice. 81 (3): pp. 377-380.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/18151
dc.identifier.doi10.1016/j.diabres.2008.05.011
dc.description.abstract

Aim: To compare the prevalence of metabolic syndrome (MetS) by combinations of MetS components derived from the National Cholesterol Education Program Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF) definitions. Methods: Four studies with ethnically distinct populations from the Asia-Pacific region were selected from the DETECT-2 study database. The prevalences of combinations of MetS components using the modified ATPIII (modATPIII) and IDF MetS definitions were compared between sexes and across populations. Results: A total of 22,952 participants from Australia, Japan, Korea and Samoa were included. The age-adjusted prevalence of modATPIII MetS varied from 9.4 to 35.8% in men and 10.3 to 57.2% in women; results for IDF were generally higher. Prevalences of the 16 possible MetS component combinations from the modATPIII definition that result in a diagnosis of MetS ranged from 0 to 12.7%. Of those with IDF-defined abdominal obesity, the prevalences of the 11 IDF-defined MetS component combinations ranged from 0.2 to 18.3%. Conclusions: The large variation in the prevalence of possible MetS component combinations to diagnose MetS may explain the different risk of cardiovascular outcomes associated with MetS in different populations, especially since particular combinations of MetS components are associated with different risk of cardiovascular disease. © 2008 Elsevier Ireland Ltd. All rights reserved.

dc.publisherElsevier Ireland Ltd
dc.titleThe metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region
dc.typeJournal Article
dcterms.source.volume81
dcterms.source.number3
dcterms.source.startPage377
dcterms.source.endPage380
dcterms.source.issn0168-8227
dcterms.source.titleDiabetes Research and Clinical Practice
curtin.departmentSchool of Public Health
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record